Cairo – Mubasher: The net profits after tax of Alexandria Pharmaceuticals and Chemical Industries declined by 22.50% year-on-year (YoY) during the period from July 2021 to January 2022.
The company logged net profits worth EGP 66.01 million in the first seven months (7M) of fiscal year (FY) 2021/2022, compared to EGP 85.15 million in the corresponding period in FY20/21.
The company's total revenues increased by 0.2% to EGP 685.89 million in the seven-month period ended on 31 January 2022 from EGP 684.69 million during the same period a year earlier, according to Egyptian Exchange’s (EGX) filling.
In the first half (H1) of FY21/22, Alexandria Pharmaceuticals recorded net profits worth EGP 57.32 million, a 27.25% year-on-year (YoY) drop from EGP 79 million.
